MedTrace Logo

Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression

NCT01545843 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2023-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine whether changing sleep patterns improves response to an antidepressant medication.

Conditions

Interventions

BEHAVIORAL

Sleep scheduling

8 hours vs. 6 hours time in bed for two weeks, with either 2 hour advance of risetime, or 2 hour delay of bedtime

DRUG

Fluoxetine

20-40 mg fluoxetine daily for 8 weeks

Sponsors & Collaborators

Principal Investigators

  • J. Todd Arnedt, Ph.D. · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545843 on ClinicalTrials.gov